Sepracor, Inc. (SEPR) to Present New STEDESA(TM) Clinical Data at American Epilepsy Society Annual Meeting  
12/2/2009 9:28:44 AM

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. today announced that clinical study data for STEDESAâ„¢ (eslicarbazepine acetate) will be presented at the 2009 annual meeting of the American Epilepsy Society (AES) in Boston. Seven posters describing new safety analyses will be presented at the Hynes Convention Center during the formal poster session on Saturday, December 5, 2009 between 1:00 pm and 8:00 pm EST. A separate Scientific Exhibit of STEDESA data will be held on Monday, December 7, 2009 from 8:00 am to 5:00 pm EST at the Sheraton Boston Hotel in Ballroom C and will include the posters presented during the poster session as well as additional posters of pharmacokinetic, safety and efficacy data and design posters for two ongoing trials.